Atrial mechanical function before and after electrical or amiodarone cardioversion in atrial fibrillation: Assessment by transesophageal echocardiography and pulsed Doppler

Echocardiography

Volumn 13, Issue 2, 1996, Pages 123-130

  Amuchastegui, Luis Maria ^a   Cravero, Cecilia ^a   Salomone, Oscar ^a   Amuchastegui, Marcos ^a  

^a HOSPITAL PRIVADO   (Argentina)

Author keywords

amiodarone; atrial fibrillation; atrial mechanical function; electrical cardioversion; pulsed Doppler; transesophageal echocardiography

Indexed keywords

AMIODARONE; HEPARIN; WARFARIN;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; BLOOD FLOW VELOCITY; CARDIOVERSION; CLINICAL ARTICLE; CONTROLLED STUDY; DOPPLER ECHOCARDIOGRAPHY; FEMALE; HEART ATRIUM FIBRILLATION; HEART ATRIUM FUNCTION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; MECHANICS; PRIORITY JOURNAL; SINUS RHYTHM; TRANSESOPHAGEAL ECHOCARDIOGRAPHY;

EID: 0029998717     PISSN: 07422822     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1540-8175.1996.tb00879.x     Document Type: Article

References (19)

1. Shapiro EP, Effron MB, Lima S, et al: Transient atrial dysfunction after conversion of chronic atrial fibrillation to sinus rhythm. Am J Cardiol 1988;62:1202-1207.
2. Santiago D, Warshofsky M, Li Mandri G, et al: Left atrial appendage function and thrombus formation in atrial fibrillation-flutter: A transesophageal echocardiographic study. JACC 1994;24:159-164.
3. Grimm RA, Stewart WJ, Maloney JD, et al: Impact of electrical cardioversion for atrial fibrillation on left atrial appendage function and spontaneous echo contrast: Characterization by simultaneous transesophageal echocardiography. JACC 1993;22:1359-1366.
4. Fatkin D, Kuchar DL, Thorbum CW, et al: Transesophageal echocardiography before and during direct current cardioversion of atrial fibrillation: Evidence for "atrial stunning" as a mechanism of thromboembolic complications. JACC 1994;23:307-316.
5. Pollick C, Taylor D: Assessment of left atrial appendage function by transesophageal echocardiography: Implications for the development of thrombus. Circulation 1991;84:223-231.
6. Laupacis A, Albers G, Dunn M, et al: Antithrombotic therapy in atrial fibrillation. 3rd ACCP Conference on Antithrombotic Therapy. Chest 1992;102(Suppl):426-433.
7. Manning WJ, Leeman DE, Gotch PJ, et al: Pulsed Doppler evaluation of atrial mechanical function after electrical cardioversion of atrial fibrillation. JACC 1989;13:617-623.
8. Grimm RA, Stewart WJ, Black IW, et al: Should all patients undergo transesophageal echocardiography before electrical cardioversion of atrial fibrillation. JACC 1994;23:533-541.
9. Black IW, Chesterman CN, Hopkins AP, et al: Hematologic correlates of left atrial spontaneous echo contrast and thromboembolism in nonvalvular atrial fibrillation. JACC 1993;21:451-457.
10. Lip GY, Tean KN, Dunn FG: Treatment of atrial fibrillation in a district general hospital. Br Heart J 1994;71:92-95.
11. Kannel WB, Wolf PA: Epidemiology of atrial fibrillation. In Falk RH, Podrid PJ (eds): Atrial Fibrillation: Mechanisms and Management. Raven Press, New York, 1992, pp. 81-92.
12. Pritchett ELC: Management of atrial fibrillation. N Engl J Med 1992;326:1264-1271.
13. Coplen SE, Antman EM, Berlin JA, et al: Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion. Circulation 1990;82:1106-1116.
14. Grimm RA, Klein AL: The role of transesophageal echocardiography in electrical cardioversion of atrial fibrillation. Highlights Learning Center Am Coll Cardiol 1994;10:1-10.
15. Manning WJ, Silverman DI, Stephen PF, et al: Cardioversion from atrial fibrillation without prolonged anticoagulation with use of transesophageal echocardiography to exclude the presence of atrial thrombi. N Engl J Med 1993;328:750-755.
16. Colatsky TJ, Follmer CH, Starmer F: Channel specificity in antiarrhythmic drug action. Mechanism of potassium channel block and its role in suppressing and aggravating cardiac arrhythmias. Circulation 1990;82:2235-2241.
17. Blanco HA, Vetulli HM, Davidenko JM, et al: Effects of verapamil and amiodarone on calcium-induced arrhythmias in the rat. JACC 1983;1:647.
18. ++ exchange. Gen Pharmacol 1993;24:305-310.
19. Ranger S, Talajic M, Lemery R, et al: Kinetics of use-dependent ventricular conduction slowing by antiarrhythmic drugs in humans. Circulation 1991;83:1987-1994.